These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17523003)
1. Porous carrier based floating granular delivery system of repaglinide. Jain SK; Agrawal GP; Jain NK Drug Dev Ind Pharm; 2007 Apr; 33(4):381-91. PubMed ID: 17523003 [TBL] [Abstract][Full Text] [Related]
2. A novel calcium silicate based microspheres of repaglinide: in vivo investigations. Jain SK; Agrawal GP; Jain NK J Control Release; 2006 Jun; 113(2):111-6. PubMed ID: 16759733 [TBL] [Abstract][Full Text] [Related]
3. Controlled release calcium silicate based floating granular delivery system of ranitidine hydrochloride. Jain AK; Jain SK; Yadav A; Agrawal GP Curr Drug Deliv; 2006 Oct; 3(4):367-72. PubMed ID: 17076638 [TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of porous carrier-based floating granular delivery system of orlistat. Jain SK; Agrawal GP; Jain NK PDA J Pharm Sci Technol; 2008; 62(4):292-9. PubMed ID: 19174957 [TBL] [Abstract][Full Text] [Related]
5. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. Jain SK; Awasthi AM; Jain NK; Agrawal GP J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. Jain SK; Agrawal GP; Jain NK AAPS PharmSciTech; 2006 Nov; 7(4):90. PubMed ID: 17233542 [TBL] [Abstract][Full Text] [Related]
7. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209 [TBL] [Abstract][Full Text] [Related]
8. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. Rawat MK; Jain A; Singh S J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451 [TBL] [Abstract][Full Text] [Related]
9. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC. Sankalia JM; Sankalia MG; Mashru RC J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362 [TBL] [Abstract][Full Text] [Related]
10. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. Patel A; Modasiya M; Shah D; Patel V AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224 [TBL] [Abstract][Full Text] [Related]
11. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits. Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637 [TBL] [Abstract][Full Text] [Related]
12. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. Rawat MK; Jain A; Singh S J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449 [TBL] [Abstract][Full Text] [Related]
13. Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Li S; Lin S; Daggy BP; Mirchandani HL; Chien YW Int J Pharm; 2003 Mar; 253(1-2):13-22. PubMed ID: 12593933 [TBL] [Abstract][Full Text] [Related]
14. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide. Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152 [TBL] [Abstract][Full Text] [Related]
15. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note. Ige PP; Gattani SG Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196 [TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet. Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710 [TBL] [Abstract][Full Text] [Related]
17. Formulation and development of gastroretentive drug delivery system for ofloxacin. Ali J; Hasan S; Ali M Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848 [TBL] [Abstract][Full Text] [Related]
18. Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation. Thakkar S; More N; Sharma D; Kapusetti G; Kalia K; Misra M Drug Dev Ind Pharm; 2019 Dec; 45(12):1921-1930. PubMed ID: 31625774 [No Abstract] [Full Text] [Related]
19. Development and evaluation of gastroretentive norfloxacin floating tablets. Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145 [TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion. Karami Z; Saghatchi Zanjani MR; Nasihatsheno N; Hamidi M J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):717-728. PubMed ID: 31187938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]